Allarity Therapeutics (ALLR) Non Operating Income (2023 - 2026)
Allarity Therapeutics' (ALLR) quarterly Non Operating Income came in at -$62000.0 in Q1 2026, down 120.39% YoY from $304000.0 in Q1 2025, and up 86.37% on a QoQ basis from -$455000.0 in Q4 2025.
Allarity Therapeutics (ALLR) Non Operating Income (2023 - 2026) Analysis & Trends
Allarity Therapeutics (ALLR) has 4 years of Non Operating Income data on file, last reported at -$62000.0 in Q1 2026.
- Quarterly Non Operating Income fell 120.39% year-over-year to -$62000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.0 million (down 55.32% YoY) and the FY2025 annual result came in at $1.4 million, down 41.41% from the prior year.
- Non Operating Income improved to -$62000.0 in Q1 2026, from -$455000.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $3.2 million in Q4 2023 to a low of -$455000.0 in Q4 2025.
- A 4-year average of $689846.2 and a median of $316000.0 in 2023 frame the typical range for Non Operating Income.
- Annual changes were most pronounced in 2024 — Non Operating Income soared 1747.62% — and 2025, when it tumbled 234.56%.
- Tracing ALLR's Non Operating Income over 4 years: stood at $3.2 million in 2023, then sank by 104.2% to -$136000.0 in 2024, then plunged by 234.56% to -$455000.0 in 2025, then surged by 86.37% to -$62000.0 in 2026.
- The last three Non Operating Income figures came in at -$62000.0 (Q1 2026), -$455000.0 (Q4 2025), and -$288000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 234.30 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -53.64 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -51.63 Mn |
| 10 | Allarity Therapeutics | 22.75 Mn | 22.75 Mn | - | -734,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -62,000.00 |
| Dec 31, 2025 | -455,000.00 |
| Sep 30, 2025 | -288,000.00 |
| Jun 30, 2025 | 1.81 Mn |
| Mar 31, 2025 | 304,000.00 |
| Dec 31, 2024 | -136,000.00 |
| Sep 30, 2024 | 346,000.00 |
| Jun 30, 2024 | 1.74 Mn |
| Mar 31, 2024 | 393,000.00 |
| Dec 31, 2023 | 3.24 Mn |
| Sep 30, 2023 | -21,000.00 |
| Jun 30, 2023 | 1.78 Mn |
| Mar 31, 2023 | 316,000.00 |